Impact of nonalcoholic hepatic steatosis on the warranty period of a coronary artery calcium score of 0: results from the multi-ethnic study of atherosclerosis

K Ichikawa, J Lim, RL McClelland… - Circulation …, 2024 - ahajournals.org
BACKGROUND: For individuals with a coronary artery calcium (CAC) score of 0, CAC
rescans at appropriate timings are recommended, depending on individual risk profiles …

The association between metabolic dysfunction-associated steatotic liver disease, cardiovascular and cerebrovascular diseases and the thickness of carotid plaque

Y Huang, Y Wang, Z Xiao, S Yao, Y Tang… - BMC Cardiovascular …, 2023 - Springer
Background The relationship between metabolic dysfunction-associated steatotic liver
disease (MASLD) and atherosclerosis has been controversial, which has become a hit of …

Coronary artery disease is more severe in patients with non-alcoholic steatohepatitis than fatty liver

T Niikura, K Imajo, A Ozaki, T Kobayashi, M Iwaki… - Diagnostics, 2020 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is associated with a higher risk of atherosclerotic
disease. However, the relationships between the severity of coronary atherosclerosis and …

Solitary kidney and risk of chronic kidney disease

S Kim, Y Chang, YR Lee, HS Jung, YY Hyun… - European Journal of …, 2019 - Springer
The renal outcome of solitary kidney remains controversial. We examined the longitudinal
association of congenital or acquired solitary kidney with the development of chronic kidney …

TRIB1 rs17321515 gene polymorphism increases the risk of coronary heart disease in general population and non-alcoholic fatty liver disease patients in Chinese …

Q Liu, SS Liu, ZZ Zhao, BT Zhao, SX Du… - Lipids in Health and …, 2019 - Springer
Background Present evidences suggested that TRIB1 rs17321515 polymorphism was tightly
associated with the increased risk of NAFLD and CHD. CHD is one of the main …

[HTML][HTML] Position statement on the diagnosis and management of non-alcoholic fatty liver disease

KA Alswat, HI Fallatah, B Al-Judaibi… - Saudi Medical …, 2019 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is a major national and international health
burden. It is one of the most common liver diseases worldwide and the most common cause …

Association between coronary artery plaque progression and liver fibrosis biomarkers in population with low calcium scores

TY Tsai, PF Hsu, CH Wu, SS Huang, WL Chan, SJ Lin… - Nutrients, 2022 - mdpi.com
Background: The severity of nonalcoholic fatty liver disease (NAFLD) has been found to be
associated with atherosclerosis burden. However, whether liver fibrosis scores can be used …

“Not all forms of NAFLD were created equal”. Do metabolic syndrome-related NAFLD and PNPLA3-related NAFLD exert a variable impact on the risk of early carotid …

A Lonardo, S Ballestri, G Targher - Atherosclerosis, 2017 - atherosclerosis-journal.com
Nonalcoholic fatty liver disease (NAFLD), which defines alcohollike liver histologic changes
in nonalcoholic individuals who are free of any other competing etiologies of liver disease, is …

The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation‐wide Cohort Study

Y Park, DH Sinn, JH Oh, MJ Goh, K Kim, W Kang… - Hepatology, 2021 - journals.lww.com
Methods and Results In this study, we found that SAL alleviated lipid accumulation and
inflammatory response in primary hepatocytes after palmitic acid/oleic acid (PO) stimulation …

Liver fibrosis is associated with ischemic stroke risk in women but not men: the REGARDS study

NS Parikh, I Koh, LB VanWagner, MSV Elkind… - Journal of Stroke and …, 2021 - Elsevier
Background Nonalcoholic fatty liver disease is inconsistently associated with ischemic
stroke, with one study suggesting an association in women and not men. The relative …